chr19-58356201-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198458.3(ZNF497):āc.1435T>Cā(p.Phe479Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000295 in 1,599,238 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00018 ( 0 hom., cov: 34)
Exomes š: 0.00031 ( 0 hom. )
Consequence
ZNF497
NM_198458.3 missense
NM_198458.3 missense
Scores
3
4
12
Clinical Significance
Conservation
PhyloP100: 2.17
Genes affected
ZNF497 (HGNC:23714): (zinc finger protein 497) Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.17860144).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF497 | NM_198458.3 | c.1435T>C | p.Phe479Leu | missense_variant | 3/3 | ENST00000311044.8 | NP_940860.2 | |
ZNF497 | NM_001207009.2 | c.1435T>C | p.Phe479Leu | missense_variant | 2/2 | NP_001193938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF497 | ENST00000311044.8 | c.1435T>C | p.Phe479Leu | missense_variant | 3/3 | 2 | NM_198458.3 | ENSP00000311183.2 | ||
ZNF497 | ENST00000425453.3 | c.1435T>C | p.Phe479Leu | missense_variant | 2/2 | 1 | ENSP00000402815.2 | |||
ENSG00000268230 | ENST00000600123.5 | n.25T>C | non_coding_transcript_exon_variant | 1/8 | 1 | |||||
ENSG00000268230 | ENST00000599109.5 | n.699+1384T>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152240Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
27
AN:
152240
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000280 AC: 66AN: 235376Hom.: 0 AF XY: 0.000349 AC XY: 45AN XY: 129072
GnomAD3 exomes
AF:
AC:
66
AN:
235376
Hom.:
AF XY:
AC XY:
45
AN XY:
129072
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000307 AC: 444AN: 1446880Hom.: 0 Cov.: 30 AF XY: 0.000316 AC XY: 227AN XY: 717810
GnomAD4 exome
AF:
AC:
444
AN:
1446880
Hom.:
Cov.:
30
AF XY:
AC XY:
227
AN XY:
717810
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000177 AC: 27AN: 152358Hom.: 0 Cov.: 34 AF XY: 0.000201 AC XY: 15AN XY: 74508
GnomAD4 genome
AF:
AC:
27
AN:
152358
Hom.:
Cov.:
34
AF XY:
AC XY:
15
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
28
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2022 | The c.1435T>C (p.F479L) alteration is located in exon 3 (coding exon 1) of the ZNF497 gene. This alteration results from a T to C substitution at nucleotide position 1435, causing the phenylalanine (F) at amino acid position 479 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MutPred
Gain of MoRF binding (P = 0.1046);Gain of MoRF binding (P = 0.1046);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at